Exosomes as Biomarkers to Monitor Disease Progression and Response to Therapy in Ewing sarcoma |
Children’s Mercy / Glenson Samuel, MD |
Young Investigator Grants |
2014 |
Missouri |
Targeted Polymeric Parthenolide Carriers to Treat Childhood AML |
University of Rochester / Danielle Benoit |
Young Investigator Grants |
2010 |
New York |
Chemical Genetics and CRISPRi/a Screen for Novel Therapeutic Targets in a Humanized Model for MYCN Associated High-Risk Pediatric Neuroblastoma |
University of California San Francisco / Zhenyi An, PhD |
Young Investigator Grants |
2015 |
California |
Assess the activity of ABT-737 as a single agent against neuroblastoma cell lines grown in cell culture
|
Children’s Hospital Los Angeles / Theresa Harned, MD |
Young Investigator Grants |
2006 |
California |
Identification and Validation of Differentiation Therapy for Osteosarcoma
|
Dana-Farber Cancer Institute / Katherine Janeway, MD |
Young Investigator Grants |
2008 |
Massachusetts |
Interrogating the Enhancer Landscapes of Ependymoma to Inform Novel Therapies |
Baylor College of Medicine / Stephen Mack, PhD |
Young Investigator Grants |
2016 |
Texas |
NUDT15 Polymorphisms and Individualization of Thiopurine Therapy in Children with Acute Lymphoblastic Leukemia |
St. Jude Children’s Research Hospital / Takaya Moriyama, MD/PhD |
Young Investigator Grants |
2018 |
Tennessee |
Identification of Resistance Mechanisms and Novel Therapeutic Strategies in Tyrosine Kinase Inhibitor Resistant FLT3/ITD Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center / Katherine Tarlock, MD |
Young Investigator Grants |
2014 |
Washington |
Targeting polycomb-mediated epigenetic silencing in T cell acute lymphoblastic leukemia |
Vanderbilt University Medical Center / Emmanuel Volanakis |
Young Investigator Grants |
2011 |
Tennessee |
Development and Characterization of Novel Models of Human Osteosarcoma Development and Metastasis |
University of Minnesota / Beau Webber, PhD |
Young Investigator Grants |
2017 |
Minnesota |